EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS133-21317 
Organism
Homo sapiens 
Tissue/cell
melanoma 
Coordinate
chr22:36366410-36368490 
Target genes
TF binding sites/motifs
Number: 8             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr22:36367558-36367576CCTTCCTCCCTCTCTTCT-6.1
EWSR1-FLI1MA0149.1chr22:36367554-36367572CATTCCTTCCTCCCTCTC-6.34
Gfi1bMA0483.1chr22:36366439-36366450AAATCTCAGCA+6.32
MEF2AMA0052.3chr22:36368248-36368260GCTATTTTTAGA-6.52
MEF2BMA0660.1chr22:36368248-36368260GCTATTTTTAGA-6.22
MEF2CMA0497.1chr22:36368247-36368262TGCTATTTTTAGAAA-7.29
SOX10MA0442.2chr22:36366785-36366796AAAACAAAGCA+6.02
ZNF263MA0528.1chr22:36367562-36367583CCTCCCTCTCTTCTCTGCTCC-6.2
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_47016chr22:36367639-36367961Ovary
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr223636756336368299
Number: 1             
IDChromosomeStartEnd
GH22I035969chr223636576036371116
Enhancer Sequence
ATGTGGCTGG GCATAGTGAC TTATGCCTGA AATCTCAGCA CTTTGGGAGG CTGAGGCAGG 60
AGGACTGCTC AAGGTCAGGA GCTCAAGACC AGCCTGGGCA ATACAGTGAG ACCCATCTCA 120
AAAAAAAAAA AAACACACAC ACTCTTCAAT TAACCAGGCA TGCTGGCATG TACCTGTAGT 180
CCCAGCTACT TTGGAGACTG AGGTAGGAGG ATTGCTTGAG CCCAGGAGCT CGGGACTGCA 240
GTGAGCCATG ATTGCACCAC TGTACTCCAG CCTGGGCAAC ACAACAGAGT GAGACCCTAT 300
CTAAAAAAAC AAGAAGAAGA AATGTGATCA TGGTGCTTAC GAGAGGACAA AAGGGACACA 360
AAGTATGAAG AGGTCAAAAC AAAGCAATGC TGCTAAGGCC TTTATGCCAA CACAGTATAT 420
TTTTACATAG TCTATCCTAA TAAGCTCACA TTTACGCAAC AACATCAGTA CAACAGCTGA 480
GTGGATTAGA ATAAAATTGC AAAGACCTAA ATGGACCCCT GGGATGGCAG AGTTTCTGTA 540
ATCATCAGCT AGACCCAAAA AACTAACAGT CAATACCAGG CATACCCTCA GTCTAACCAG 600
GCAACCAAAA TAGAAGCAAA ATAGAAAATC AAGTATATAT ATAAAATATA TCCCTGGTGG 660
AATCAGGAGG GCACAAAAGA ACAATTCATA GTGCCTGCAG CTGAGTGTCA CCAAAAAAAT 720
CCTCTTTTAA GCTGTGCAGA GTGCCTGATA TACTGCAGTA GGTGGGAAAA CGGCCAAATT 780
CAAGCCCACG TCAGAGCACA CCAGGTATGC TCCCCTGGCA ACAATACTAC ATGGGATGTG 840
GGTGCAAAAC ACCTTCCTAC TTCCTTTAAG TTTAAAGTCA CTGTCACACT CACCCTTTGG 900
CACACAGCTA CACAGGGCCA GTGATACTCA GTTTACAATG TAAATAAACC ATCCCCATGC 960
AATGTTATAT TTTGAACCAT TCAGACAAGT GTGCAGGATT CAAAAAAATG AAAAATAAAG 1020
AGTGGCTTGT TTTTCCAAGT CTCATTCACA TTCTCATGTT CCCAATCCCC ATTTCTAGCA 1080
AATGCCTCCC AGGTCCAGAA AAAAATTCCT TTCCTAAATA TTCACCATCT GCGTTTAATT 1140
TGGCCATTCC TTCCTCCCTC TCTTCTCTGC TCCCAACCCA CAAGAAACAT ATACATATGT 1200
TTATGTTTAT ATATACATAT CTCCCCTCCT TTTAACATTC CCTGAAAACA AATATAGAAA 1260
AGATTAGAAA GGAAAAGAGA CTAGGAGAGG GAGGTAAACA GGGCAGGCAA AGGGAGCAGT 1320
TCACAGAATG AGGCACAAAG ACAACATGAG ACGGTTGCTC TTGAGCTCCA GCAGTAAGGG 1380
CTGTTTCTGA TTAGGTGCAT ACAATTGCAG AGCTGCACAG GAAGTGCTGA GGGGGCCTTC 1440
TTGGTCAGCC CCATCCCAAA CACACTGAAA ACCTTTGTAC TGTAGCAGGC CCATCTGGAA 1500
TCAGTTAGGA CCAAGCTCCT AGCAGCCTTT CCTTTTTTCT TTTTCTCCCT AAAAAAAAAA 1560
AAAAAAAAAA AAAAAACACT CTCTAAAACC ACTTAGCTCA GTTTTCCTGC CTGCAACCTT 1620
CTCATCCCTT CCTTCCAGAT CATCCCTTCC TTCCAAATCA CCCTTCGGAA CATATTTCTC 1680
CCACTGCCCT TCTGGGGTCA CCACTAACAA GATGAGTCAT ATAAGAACAT AAAGCATTCA 1740
GAGAGCTAGC ATCCTCCCTA GAGCCCAGAA ACCCCCCAAA CAGTATAGTC TTCATGCAAC 1800
TAAAATCCCT TTTTAGATCA TTTTGGGGTT TTTTAAATGC TATTTTTAGA AATTTGAAGT 1860
GGCCTGCTTT TTTTAAGCAT TTAAATGAAG CACCTCCTTT AGGGAACTGT TTTCATGTGT 1920
TCTATCTTCT AAATCATGCA AAAAGTAGGA AAAAAAGAAA CTCTGGCATA GTTCTCCTAG 1980
CATTCAAAAG GAAAAATATG TTTCCATTCA CAATCCTAAG TCAAACCGCT TATATTCGTT 2040
TCTGTAAAAT TGATTTTTAC TAATGCTTCC TCAAAAAAAA 2080